[link|324|MedGel website] is a privately-held RD company started in 2004 as a spin-off from Kyoto University. The company sells materials for animal tissue culture and is involved in tests on drug delivery systems. Capital is 100 million Yen (~ 900 T€). Chairman is Dr Tomohiko ASAHARA.